The role of cytokines in classical Hodgkin lymphoma
Top Cited Papers
Open Access
- 15 June 2002
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 99 (12) , 4283-4297
- https://doi.org/10.1182/blood-2002-01-0099
Abstract
The clinical and pathologic features of classical Hodgkin lymphoma (cHL) reflect an abnormal immune response that is thought to be due to the elaboration of a vKeywords
This publication has 151 references indexed in Scilit:
- Functional expression of receptor activator of nuclear factor κB in Hodgkin disease cell linesBlood, 2001
- Expression of the Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg CellsLaboratory Investigation, 2000
- STATs in oncogenesisOncogene, 2000
- The biology of Stat4 and Stat6Oncogene, 2000
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Serum concentrations of cytokines in patients with Hodgkin's diseaseEuropean Journal Of Cancer, 1994
- Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cellsImmunology Today, 1994
- Increased levels of circulating interleukin‐6 in patients with hodgkin's diseaseHematological Oncology, 1991
- Anti-interleukin-1 reactive cells in Hodgkin's diseaseCancer, 1987
- Immunoprecipitation of the interleukin‐2 receptor from Hodgkin's disease derived cell lines by monoclonal antibodiesHematological Oncology, 1987